3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
4
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Prostatic Neoplasms
2
Mouth Neoplasms
2
Congenital Abnormalities
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostate Adenocarcinoma
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteoporosis
1
Oropharyngeal Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Lung Neoplasms
1
Liposarcoma
1
Interventions
Fluorouracil
8
Radiotherapy
4
Mitomycin
4
Cyclophosphamide
3
Cisplatin
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
VGX-3100
2
Specimen Handling
2
Papillomavirus Vaccines
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Light Coagulation
2
Ipilimumab
2
Cetuximab
2
CTLA-4 Antigen
2
Biopsy
2
tempol
1
rocakinogene sifuplasmid
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
alovudine
1
abiraterone
1
Yoga
1
Therapeutics
1
SRA737
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Anus Neoplasms
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts